Photoelectrochemical aptasensor based on La2Ti2O7/Sb2S3 and V2O5 for effectively signal change strategy for cancer marker detection

A ZnIn2S4@ReS2/AgInS2-based photoelectrochemical aptasensor for the ultrasensitive detection of kanamycin

An ultrasensitive photoelectrochemical (PEC) aptasensor was originally designed by using ZnIn2S4/ReS2 as a photoactive material and AgInS2 as a signal amplifier. The signal amplifier AgInS2 was incubated on the terminal of H-DNA (immobilized on the ZnIn2S4/ReS2/FTO surface), leading to an enhanced photocurrent response. Then, due to the introduction of DNA2, the formation of a double-stranded structure caused AgInS2 to keep away from the electrode surface, and the photocurrent was reduced. In the presence of kanamycin, DNA2 was released from the system due to the competition relationship, and a restored photocurrent response was obtained. The combination of ZnIn2S4/ReS2 and AgInS2 accelerated the electron transfer and enhanced the separation efficiency of photogenerated electron-hole pairs, resulting in an improved performance of the PEC aptasensor, which was capable of accurate and sensitive detection of kanamycin in actual samples.

Recent advances in electrochemical nanomaterial-based aptasensors for the detection of cancer biomarkers

New technologies have provided suitable tools for rapid diagnosis of cancer which can reduce treatment costs and even increase patients' survival rates. Recently, the development of electrochemical aptamer-based nanobiosensors has raised great hopes for early, sensitive, selective, and low-cost cancer diagnosis. Here, we reviewed the flagged recent research (2021-2023) developed as a series of biosensors equipped with nanomaterials and aptamer sequences (nanoaptasensors) to diagnose/prognosis of various types of cancers. Equipping these aptasensors with nanomaterials and using advanced biomolecular technologies have provided specified biosensing interfaces for more optimal and reliable detection of cancer biomarkers. The primary intention of this review was to present and categorize the latest innovations used in the design of these diagnostic tools, including the hottest surface modifications and assembly of sensing bioplatforms considering diagnostic mechanisms. The main classification is based on applying various nanomaterials and sub-classifications considered based on the type of analyte and other vital features. This review may help design subsequent electrochemical aptasensors. Likewise, the up-to-date status, remaining limitations, and possible paths for translating aptasensors to clinical cancer assay tools can be clarified.

A signal "on-off-on"-type electrochemiluminescence aptamer sensor for detection of sulfadimethoxine based on Ru@Zn-oxalate MOF composites

An "on-off-on"-type electrochemiluminescence (ECL) aptamer sensor based on Ru@Zn-oxalate metal-organic framework (MOF) composites is constructed for sensitive detection of sulfadimethoxine (SDM). The prepared Ru@Zn-oxalate MOF composites with the three-dimensional structure provide good ECL performance for the "signal-on." The MOF structure with a large surface area enables the material to fix more Ru(bpy)₃²⁺. Moreover, the Zn-oxalate MOF with three-dimensional chromophore connectivity provides a medium which can accelerate excited-state energy transfer migration among Ru(bpy)₃²⁺ units, and greatly reduces the influence of solvent on chromophore, achieving a high-energy Ru emission efficiency. The aptamer chain modified with ferrocene at the end can hybridize with the capture chain DNA1 fixed on the surface of the modified electrode through base complementary pairing, which can significantly quench the ECL signal of Ru@Zn-oxalate MOF. SDM specifically binds to its aptamer to separate ferrocene from the electrode surface, resulting in a "signal-on" ECL signal. The use of the aptamer chain further improves the selectivity of the sensor. Thus, high-sensitivity detection of SDM specificity is realized through the specific affinity between SDM and its aptamer. This proposed ECL aptamer sensor has good analytical performance for SDM with low detection limit (27.3 fM) and wide detection range (100 fM-500 nM). The sensor also shows excellent stability, selectivity, and reproducibility, which proved its analytical performance. The relative standard deviation (RSD) of SDM detected by the sensor is between 2.39 and 5.32%, and the recovery is in the range 97.23 to 107.5%. The sensor shows satisfactory results in the analysis of actual seawater samples, which is expected to play a role in the exploration of marine environmental pollution.

2D carbon materials based photoelectrochemical biosensors for detection of cancer antigens

Cancer is a leading cause of death globally and early diagnosis is of paramount importance for identifying appropriate treatment pathways to improve cancer patient survival. However, conventional methods for cancer detection such as biopsy, CT scan, magnetic resonance imaging, endoscopy, X-ray and ultrasound are limited and not efficient for early cancer detection. Advancements in molecular technology have enabled the identification of various cancer biomarkers for diagnosis and prognosis of the deadly disease. The detection of these biomarkers can be done by biosensors. Biosensors are less time consuming compared to conventional methods and has the potential to detect cancer at an earlier stage. Compared to conventional biosensors, photoelectrochemical (PEC) biosensors have improved selectivity and sensitivity and is a suitable tool for detecting cancer agents. Recently, 2D carbon materials have gained interest as a PEC sensing platform due to their high surface area and ease of surface modifications for improved electrical transfer and attachment of biorecognition elements. This review will focus on the development of 2D carbon nanomaterials as electrode platform in PEC biosensors for the detection of cancer biomarkers. The working principles, biorecognition strategies and key parameters that influence the performance of the biosensors will be critically discussed. In addition, the potential application of PEC biosensor in clinical settings will also be explored, providing insights into the future perspective and challenges of exploiting PEC biosensors for cancer diagnosis.

Highly Sensitive Photoelectrochemical Biosensor for MicroRNA-21 Based on a Dumbbell-Shaped Heterostructure AuNRs@end-TiO2 Combined with Carbon Dots as Photosensitizers and Duplex-Specific Nuclease-Assisted Signal Amplification

TiO₂ was grown on both ends of gold nanorods (AuNRs) to form a dumbbell-shaped heterostructure (called AuNRs@end-TiO₂) first, and then assembled on the fluorine tin oxide (FTO) electrode surface through hydrophobic interactions to construct a concise photoelectrochemical microRNA-21 (miRNA-21, model target) biosensor using carbon dots (CDs) as photosensitizers. Hairpin probes (HPs) were fixed on the AuNRs@end-TiO₂-modified FTO electrode surface through the Au-S bond, and CDs-modified complementary DNA (CDs-cDNA) served as photosensitive probes. In the presence of the target, miRNA hybridized with the HP and triggered double-strand-specific nuclease to cleave the complementary part of the HP with miRNA, and miRNA was released, which can trigger another cycle to realize signal amplification. Many HPs were cleaved and the complementary sequence with cDNA was exposed, which can capture the photosensitive probes to the electrode surface and resulted in photocurrent enhancement. The photocurrent intensity system has a linear relationship with the logarithm of the miRNA concentration in the range of 0.1 fM to 100 pM with a low detection limit of 96 aM (S/N = 3). The biosensor has high sensitivity, good selectivity, and good reproducibility and shows satisfactory results in actual sample detection.

Au NP-Decorated g-C3N4-Based Photoelectochemical Biosensor for Sensitive Mercury Ions Analysis

Herein, an efficient and feasible photoelectrochemical (PEC) biosensor based on gold nanoparticle-decorated graphitic-like carbon nitride (Au NPs@g-C₃N₄) with excellent photoelectric performance was designed for the highly sensitive detection of mercury ions (Hg²⁺) . The proposed Au NPs@g-C₃N₄ was first modified on the surface of the electrode, which possessed a remarkable photocurrent conversion efficiency and could produce a strong initial photocurrent. Then, the thymine-rich DNA (S1) was immobilized on the surface of the modified electrode via Au-N bonds. Subsequently, 1-hexanethiol (HT) was added to the resultant electrode to block nonspecific binding sites. Finally, the target Hg²⁺ was incubated on the surface of the modified glassy carbon electrode (GCE). In the presence of target Hg²⁺, the thymine-Hg²⁺-thymine (T-Hg²⁺-T) structure formed due to the selective capture capability of thymine base pairs toward Hg²⁺, resulting in the significantly decrease of the photocurrent. Thereafter, the proposed PEC biosensor was successfully used for sensitive Hg²⁺ detection, as it possessed a wide linear range from 1 pM to 1000 nM with a low detection limit of 0.33 pM. Importantly, this study demonstrates a new method of detecting Hg²⁺ and provides a promising platform for the detection of other heavy metal ions of interest.

Cancer Diagnostics and Early Detection Using Electrochemical Aptasensors

The detection of early-stage cancer offers patients the best chance of treatment and could help reduce cancer mortality rates. However, cancer cells or biomarkers are present in extremely small amounts in the early stages of cancer, requiring high-precision quantitative approaches with high sensitivity for accurate detection. With the advantages of simplicity, rapid response, reusability, and a low cost, aptamer-based electrochemical biosensors have received considerable attention as a promising approach for the clinical diagnosis of early-stage cancer. Various methods for developing highly sensitive aptasensors for the early detection of cancers in clinical samples are in progress. In this article, we discuss recent advances in the development of electrochemical aptasensors for the early detection of different cancer biomarkers and cells based on different detection strategies. Clinical applications of the aptasensors and future perspectives are also discussed.